Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients-An unrecognized CF pathogen?

International Journal of Medical Microbiology

Volumn 304, Issue 3-4, 2014, Pages 415-421

  Barillova, Petra ^a,b   Tchesnokova, Veronika ^b   Dübbers, Angelika ^a   Küster, Peter ^c   Peters, Georg ^a   Dobrindt, Ulrich ^a   Sokurenko, Evgeni V ^b   Kahl, Barbara C ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Department of Pediatrics ^*  (Germany)

Author keywords

Airways; Colonization; Cystic fibrosis; Escherichia coli; Pathoadaptation; Persistence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CLONAL SPECIES; CYSTIC FIBROSIS; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTICENTER STUDY; PATHOGENESIS; PHENOTYPIC VARIATION; PREVALENCE; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; THROAT CULTURE; CLASSIFICATION; COMPLICATION; EPIDEMIOLOGY; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETICS; GENOTYPE; GERMANY; HETEROZYGOTE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PHARYNX; PRESCHOOL CHILD; SPUTUM; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIAL LOAD; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; GERMANY; HUMANS; INFANT; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PHARYNX; PREVALENCE; SPUTUM; YOUNG ADULT;

EID: 84899628640     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.02.008     Document Type: Article

References (30)

1. Bures J., Cyrany J., Kohoutova D., Forstl M., Rejchrt S., Kvetina J., Vorisek V., Kopacova M. Small intestinal bacterial overgrowth syndrome. World J. Gastroenterol. 2010, 16:2978-2990.
2. Burkett A., Vandemheen K.L., Giesbrecht-Lewis T., Ramotar K., Ferris W., Chan F., Doucette S., Fergusson D., Aaron S.D. Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:1603-1610.
3. Carlson D., McKeen E., Mitchell M., Torres B., Parad R., Comeau A.M., O'Sullivan B.P. Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care. Pediatr. Pulmonol. 2009, 44:497-502.
4. CLSI Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standards 2012, Clinical and Laboratory Standards Institute, Wayne, PA. 11th ed.
5. Cramer N., Wiehlmann L., Ciofu O., Tamm S., Hoiby N., Tummler B. Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS ONE 2012, 7:e50731.
6. Cremet L., Caroff N., Giraudeau C., Reynaud A., Caillon J., Corvec S. Detection of clonally related Escherichia coli isolates producing different CMY beta-lactamases from a cystic fibrosis patient. J. Antimicrob. Chemother. 2013, 68:1032-1035.
7. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry - 2010. Annual Data Report. Bethesda, MD, USA 2011.
8. Duriez P., Clermont O., Bonacorsi S., Bingen E., Chaventre A., Elion J., Picard B., Denamur E. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001, 147:1671-1676.
9. Hauser A.R., Jain M., Bar-Meir M., McColley S.A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 2011, 24:29-70.
10. Hoffman L.R., Ramsey B.W. Cystic fibrosis therapeutics: the road ahead. Chest 2013, 143:207-213.
11. Hoiby N. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol. Microbiol. Scand. B: Microbiol. Immunol. 1974, 82:541-550.
12. Johnson J.R., Russo T.A. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int. J. Med. Microbiol. 2005, 295:383-404.
13. Johnson J.R., Scheutz F., Ulleryd P., Kuskowski M.A., O'Bryan T.T., Sandberg T. Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J. Clin. Microbiol. 2005, 43:3895-3900.
14. Johnson J.R., Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 2000, 181:261-272.
15. Kahl B., Herrmann M., Everding A.S., Koch H.G., Becker K., Harms E., Proctor R.A., Peters G. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J. Infect. Dis. 1998, 177:1023-1029.
16. Kahl B.C., Duebbers A., Lubritz G., Haeberle J., Koch H.G., Ritzerfeld B., Reilly M., Harms E., Proctor R.A., Herrmann M., Peters G. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J. Clin. Microbiol. 2003, 41:4424-4427.
17. Lisowska A., Wojtowicz J., Walkowiak J. Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection. Acta Biochim. Pol. 2009, 56:631-634.
18. Macone A.B., Pier G.B., Pennington J.E., Matthews W.J., Goldmann D.A. Mucoid Escherichia coli in cystic fibrosis. N. Engl. J. Med. 1981, 304:1445-1449.
19. Messika J., Magdoud F., Clermont O., Margetis D., Gaudry S., Roux D., Branger C., Dreyfuss D., Denamur E., Ricard J.D. Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains. Intensive Care Med. 2012, 38:2007-2016.
20. O'May G.A., Reynolds N., Smith A.R., Kennedy A., Macfarlane G.T. Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding. J. Clin. Microbiol. 2005, 43:3059-3065.
21. O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet 2009, 373:1891-1904.
22. Ochman H., Selander R.K. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 1984, 157:690-693.
23. Schito G.C., Naber K.G., Botto H., Palou J., Mazzei T., Gualco L., Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 2009, 34:407-413.
24. Seidmon E.J., Mosovich L.L., Neter E. Colonization by Enterobacteriaceae of the respiratory tract of children with cystic fibrosis of the pancreas and their antibody response. J. Pediatr. 1975, 87:528-533.
25. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., Burns J.L., Kaul R., Olson M.V. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8487-8492.
26. Van B.S., De W.K., Van W.M., Robberecht E. Percutaneous endoscopic gastrostomy in cystic fibrosis: patient acceptance and effect of overnight tube feeding on nutritional status. Acta Gastroenterol. Belg. 2004, 67:241-244.
27. Versalovic J., Koeuth T., Lupski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991, 19:6823-6831.
28. Viviani L., Zolin A., Olesen H.V. European Cystic Fibrosis Foundation Patient Registry - Annual Data Report 2008-2009 2012.
29. Weissman S.J., Johnson J.R., Tchesnokova V., Billig M., Dykhuizen D., Riddell K., Rogers P., Qin X., Butler-Wu S., Cookson B.T., Fang F.C., Scholes D., Chattopadhyay S., Sokurenko E. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl. Environ. Microbiol. 2012, 78:1353-1360.
30. Wirth T., Falush D., Lan R., Colles F., Mensa P., Wieler L.H., Karch H., Reeves P.R., Maiden M.C., Ochman H., Achtman M. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 2006, 60:1136-1151.